Literature DB >> 1496158

Sjögren's syndrome: historical overview and clinical spectrum of disease.

N Talal1.   

Abstract

Sjögren's syndrome is a chronic autoimmune and inflammatory disease characterized by lymphocyte proliferation that progressively destroys exocrine glands. The lymphocytes can infiltrate other and more vital organs and may at times become malignant. Another name for this disease is autoimmune exocrinopathy. It was first described over 100 years ago both as a benign syndrome of oral and ocular dryness and also as a lymphoid malignancy. Thus, Sjögren's syndrome is related to the autoimmune rheumatic diseases, as well as to lymphoid B-cell malignancies.

Entities:  

Mesh:

Year:  1992        PMID: 1496158

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  14 in total

Review 1.  The role of apoptosis in the initiation of the autoimmune response in Sjögren's syndrome.

Authors:  M G Humphreys-Beher; A B Peck; H Dang; N Talal
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

Review 2.  Imaging of the pulmonary manifestations of systemic disease.

Authors:  A G Rockall; D Rickards; P J Shaw
Journal:  Postgrad Med J       Date:  2001-10       Impact factor: 2.401

Review 3.  Rational drug therapy recommendations for the treatment of patients with Sjögren's syndrome.

Authors:  P Oxholm; J U Prause; M Schiødt
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

4.  Rituximab treatment for Sjogren syndrome-associated non-Hodgkin's lymphoma: case series.

Authors:  M Covelli; E Lanciano; P Tartaglia; V Grattagliano; G Angelelli; F Atzeni; P Sarzi-Puttini; G Lapadula
Journal:  Rheumatol Int       Date:  2011-07-30       Impact factor: 2.631

Review 5.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

6.  Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables.

Authors:  I M Gilboe; T K Kvien; T Uhlig; G Husby
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

7.  Identification of specific autoantigens in Sjögren's syndrome by SEREX.

Authors:  Kazuo Uchida; Yoichi Akita; Keitaro Matsuo; Shigeyoshi Fujiwara; Atsuko Nakagawa; Yoshiaki Kazaoka; Hiroshi Hachiya; Yoshiyuki Naganawa; Ichiro Oh-Iwa; Kiyoshi Ohura; Shinsuke Saga; Tatsushi Kawai; Yoshinari Matsumoto; Kazuo Shimozato; Ken-Ichi Kozaki
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

8.  Review of the Pharmacological Properties and Clinical Usefulness of Muscarinic Agonists for Xerostomia in Patients with Sjögren's Syndrome.

Authors:  Hiroshi Yasuda; Hiroshi Niki
Journal:  Clin Drug Investig       Date:  2002       Impact factor: 2.859

9.  Sjögren's syndrome: History, clinical and pathological features.

Authors:  A L Parke; W W Buchanan
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

Review 10.  Thyroid disease in Sjögren's syndrome.

Authors:  Luis J Jara; Carmen Navarro; María del Pilar Brito-Zerón; Mario García-Carrasco; Ricardo O Escárcega; Manuel Ramos-Casals
Journal:  Clin Rheumatol       Date:  2007-06-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.